BRVE
Braveheart Bio, Inc.
21.40$
+0.4%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 26 | Q2 26 |
|---|---|---|
| 100.0% | 100.0% | |
| 99.0% | 97.2% | |
| 98.4% | 96.8% | |
| 195.7% | 175.5% | |
| 12.2% | 7.1% | |
| 9.5% | 2.1% | |
| -95.7% | -75.5% | |
| -98.1% | -75.5% | |
| 89.3% | 57.6% |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.